medmix AG (SWX:MEDX)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
8.84
+0.25 (2.91%)
Jul 31, 2026, 5:30 PM CET
Market Cap359.84M -27.6%
Revenue (ttm)437.00M -6.6%
Net Income100.00K
EPS-0.00
Shares Out 40.71M
PE Ratio3,598.43
Forward PE16.02
Dividend0.10 (1.13%)
Ex-Dividend DateApr 20, 2026
Volume201,003
Open8.63
Previous Close8.59
Day's Range8.63 - 9.02
52-Week Range7.61 - 12.56
Beta0.82
AnalystsStrong Buy
Price Target15.80 (+78.73%)
Earnings DateJul 23, 2026

About medmix AG

medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for prosthetics, restoratives, anesthetics, and aesthetics; the pen and auto injectors, which are used in fertility and growth hormone treatments, treatment of... [Read more]

Founded 1922
Employees 2,587
Stock Exchange SIX Swiss Exchange
Ticker Symbol MEDX
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for MEDX stock is "Strong Buy." The 12-month stock price target is CHF 15.80, which is an increase of 78.73% from the latest price.

Price Target
CHF 15.80
(78.73% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

medmix AG Earnings Call Transcript: H1 2026

Profitability improved in H1 2026 despite a 1.6% organic revenue decline, with adjusted EBITDA margin rising to 20.3% and gross margin up 120 bps. Healthcare led growth, especially in Surgery, while Beauty and Drug Delivery faced headwinds but are expected to stabilize in H2.

10 days ago - Transcripts

medmix AG Slides: H1 2026

medmix AG has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 23, 2026.

10 days ago - Filings

medmix AG Quarterly report: H1 2026

medmix AG has published its H1 2026 quarterly earnings report on July 23, 2026.

10 days ago - Filings

medmix AG Earnings release: H1 2026

medmix AG released its H1 2026 earnings on July 23, 2026, summarizing the period's financial results.

10 days ago - Filings

medmix AG Earnings Call Transcript: H2 2025

Gross profit and margins improved year-over-year despite revenue declines, driven by cost savings and strong dental performance. 2026 guidance calls for flat to low single-digit organic growth and stable margins, with H2 expected to outperform H1 as drug delivery headwinds subside.

5 months ago - Transcripts

medmix AG Annual report: H2 2025

medmix AG has published its H2 2025 annual report on February 26, 2026.

5 months ago - Filings

medmix AG Earnings release: H2 2025

medmix AG released its H2 2025 earnings on February 26, 2026, summarizing the period's financial results.

5 months ago - Filings

medmix AG Slides: H2 2025

medmix AG has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 26, 2026.

5 months ago - Filings